Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06740851Active Not Recruiting

Predictive Model for 1-Year Pain and Function Outcomes After Thumb Joint Surgery in Osteoarthritic Patients

Role: collaborator

NCT06366854Not ApplicableNot Yet Recruiting

UK ANDROMEDA-Shock-2 RCT

Role: collaborator

NCT04261309Completed

BACk Pain in Elders in Norway (BACE-N)

Role: collaborator

NCT03080961Not ApplicableCompleted

The VIBLOK SAfety and perFormancE Trial

Role: collaborator

NCT02175147Unknown

Patient-centred Integrated Palliative Care Pathways in Advanced Cancer and Chronic Disease

Role: collaborator

All 5 trials loaded